This study evaluates the feasibility of using claims data to evaluate risk factors for prescription opioid abuse among patients in a privately insured population.
Matt Schiller, BA
Advertisement
Articles by Matt Schiller, BA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
What ADA 2026 Data Reveal About the Growing Gap in Ketone Monitoring: Eden Miller, DO
2
GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis
3
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
4
GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale
5